Chat
Direct Coombs (Anti-Human Globulin)
0013008
Copy Utility
Ordering Recommendation
Use to detect in vivo coating of red blood cells (RBCs) with immunoglobulin and complement degradation products on the patient's RBCs. Useful for antibody identification and evaluation of transfusion reactions, hemolytic disease of the fetus and newborn (HDFN), and autoimmune hemolytic anemia associated with disease and/or drugs.
Mnemonic
IRL-DC
Methodology
Hemagglutination
Performed
Mon-Fri
Reported
1-3 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Lavender (K2EDTA) or Pink (K2EDTA).
Specimen Preparation
Do not freeze.
Transport 5 mL whole blood. (Min: 1 ml)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Separator or gel tubes.
Remarks
Stability
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable
Reference Interval
Negative
Interpretive Data
Compliance Category
FDA
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
86880
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0013008 | Direct Coombs | 13946-9 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- DAT
- Direct Antiglobulin Test
- Direct Antihuman Globulin Test
Direct Coombs (Anti-Human Globulin)
Feedback
